Symbols / OSCR $12.80 -3.76%
OSCR Chart
About
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 3.81B |
| Enterprise Value | 467.14M | Income | -443.15M | Sales | 11.70B |
| Book/sh | 3.29 | Cash/sh | 13.42 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2305 | IPO | — |
| P/E | — | Forward P/E | 9.51 | PEG | — |
| P/S | 0.33 | P/B | 3.89 | P/C | — |
| EV/EBITDA | -1.27 | EV/Sales | 0.04 | Quick Ratio | 0.92 |
| Current Ratio | 0.95 | Debt/Eq | 50.86 | LT Debt/Eq | — |
| EPS (ttm) | -1.69 | EPS next Y | 1.35 | EPS Growth | — |
| Revenue Growth | 17.30% | Earnings | 2026-05-11 | ROA | -4.44% |
| ROE | -44.35% | ROIC | — | Gross Margin | 14.38% |
| Oper. Margin | -11.90% | Profit Margin | -3.79% | Shs Outstand | 262.16M |
| Shs Float | 249.46M | Short Float | 10.75% | Short Ratio | 2.91 |
| Short Interest | — | 52W High | 23.80 | 52W Low | 11.20 |
| Beta | 1.90 | Avg Volume | 8.04M | Volume | 3.34M |
| Target Price | $15.40 | Recom | Hold | Prev Close | $13.30 |
| Price | $12.80 | Change | -3.76% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$15.40
Mean price target
2. Current target
$12.63
Latest analyst target
3. DCF / Fair value
$47.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.63
Low
$10.00
High
$23.00
Mean
$15.40
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-09 | up | UBS | Sell → Neutral | $17 |
| 2026-01-05 | up | Barclays | Underweight → Equal-Weight | $18 |
| 2025-12-11 | init | Stephens & Co. | — → Equal-Weight | $17 |
| 2025-11-26 | up | Piper Sandler | Neutral → Overweight | $25 |
| 2025-11-13 | main | Wells Fargo | Underweight → Underweight | $11 |
| 2025-11-10 | main | Barclays | Underweight → Underweight | $13 |
| 2025-11-07 | main | UBS | Sell → Sell | $12 |
| 2025-10-14 | init | Goldman Sachs | — → Neutral | $17 |
| 2025-10-07 | main | Wells Fargo | Underweight → Underweight | $14 |
| 2025-08-14 | main | Piper Sandler | Neutral → Neutral | $13 |
| 2025-07-25 | down | Baird | Outperform → Neutral | $14 |
| 2025-07-23 | main | Barclays | Underweight → Underweight | $11 |
| 2025-07-15 | down | UBS | Neutral → Sell | $11 |
| 2025-07-11 | down | Wells Fargo | Equal-Weight → Underweight | $10 |
| 2025-07-02 | init | Barclays | — → Underweight | $17 |
| 2025-06-09 | main | Piper Sandler | Overweight → Overweight | $18 |
| 2025-03-13 | down | Wells Fargo | Overweight → Equal-Weight | $16 |
| 2024-12-10 | init | Jefferies | — → Underperform | $12 |
| 2024-11-06 | down | B of A Securities | Neutral → Underperform | $14 |
| 2024-10-07 | init | UBS | — → Neutral | $23 |
- Oscar Health Inc (OSCR) Shares Down 3.91% on Mar 20 - GuruFocus Fri, 20 Mar 2026 17
- Assessing Oscar Health (OSCR) Valuation After Mixed Returns And A Possible Undervaluation Gap - simplywall.st Fri, 20 Mar 2026 15
- Oscar Health (NYSE:OSCR) Shares Up 10% - Here's Why - MarketBeat Wed, 04 Mar 2026 08
- Why Is Oscar Health (OSCR) Stock Soaring Today - Yahoo Finance Mon, 05 Jan 2026 08
- Here's the Reason Oscar Health, Inc. (OSCR) Declined More Sharply Than the Overall Market - Bitget hu, 19 Mar 2026 23
- Oscar Health (OSCR) CFO Blackley gifts 225,000 shares to family trust - Stock Titan Mon, 16 Mar 2026 20
- Time To Buy The Dip In Oscar Health Stock? - Trefis Wed, 11 Mar 2026 16
- Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back? - Forbes Wed, 25 Feb 2026 08
- Why Is OSCR Stock Rising Today? - Stocktwits ue, 10 Feb 2026 11
- Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market - Yahoo Finance Singapore hu, 19 Mar 2026 22
- Oscar Health, Inc. $OSCR Shares Bought by Farallon Capital Management LLC - MarketBeat Mon, 16 Mar 2026 10
- Is 25.4% Fall In Oscar Health (OSCR) Stock A Buying Opportunity? - Trefis Wed, 04 Feb 2026 08
- Here is What to Know Beyond Why Oscar Health, Inc. (OSCR) is a Trending Stock - Yahoo Finance Fri, 27 Feb 2026 08
- Do Analyst Upgrades Really Mark a Turning Point in Oscar Health’s (OSCR) Margin Story? - simplywall.st Mon, 16 Mar 2026 06
- Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance ue, 27 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 150000 | — | — | Stock Gift at price 0.00 per share. | BLACKLEY RICHARD SCOTT | Chief Financial Officer | — | 2026-03-12 00:00:00 | D |
| 1 | 1596877 | — | — | Stock Award(Grant) at price 0.00 per share. | BERTOLINI MARK T | Chief Executive Officer | — | 2026-03-02 00:00:00 | D |
| 2 | 134847 | — | — | Stock Award(Grant) at price 0.00 per share. | BLACKLEY RICHARD SCOTT | Chief Financial Officer | — | 2026-03-02 00:00:00 | D |
| 3 | 67424 | — | — | Stock Award(Grant) at price 0.00 per share. | MCANANEY ADAM | Officer | — | 2026-03-02 00:00:00 | D |
| 4 | 189141 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-03-02 00:00:00 | D |
| 5 | 106458 | — | — | Stock Award(Grant) at price 0.00 per share. | LIANG JANET | Officer | — | 2026-03-02 00:00:00 | D |
| 6 | 17300 | — | — | Stock Award(Grant) at price 0.00 per share. | BALTRUS VICTORIA | Officer | — | 2026-03-02 00:00:00 | D |
| 7 | 24335 | 325846.0 | — | Sale at price 13.39 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-03-02 00:00:00 | D |
| 8 | 7453 | 99796.0 | — | Sale at price 13.39 per share. | LIANG JANET | Officer | — | 2026-03-02 00:00:00 | D |
| 9 | 4638 | 62103.0 | — | Sale at price 13.39 per share. | BALTRUS VICTORIA | Officer | — | 2026-03-02 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.22 | 0.21 | 0.00 |
| TotalUnusualItems | 0.00 | 0.00 | -20.18M | |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 0.00 | -20.18M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -443.15M | 25.43M | -270.73M | -606.27M |
| ReconciledDepreciation | 28.89M | 32.15M | 30.69M | 15.28M |
| EBIT | -419.70M | 57.16M | -242.70M | -587.45M |
| NetInterestIncome | -17.60M | -23.73M | -24.60M | -22.62M |
| InterestExpense | 17.60M | 23.73M | 24.60M | 22.62M |
| InterestIncome | 31.31M | 10.25M | ||
| NormalizedIncome | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -443.15M | 25.43M | -270.73M | -606.27M |
| TotalExpenses | 12.14B | 9.14B | 6.13B | 4.74B |
| DilutedAverageShares | 262.39M | 265.85M | 221.66M | 212.47M |
| BasicAverageShares | 262.39M | 240.39M | 221.66M | 212.47M |
| DilutedEPS | -1.69 | 0.10 | -1.22 | -2.85 |
| BasicEPS | -1.69 | 0.11 | -1.22 | -2.85 |
| DilutedNIAvailtoComStockholders | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncomeCommonStockholders | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncome | -443.15M | 25.43M | -270.73M | -606.27M |
| MinorityInterests | -248.00K | -689.00K | -134.00K | 3.28M |
| NetIncomeIncludingNoncontrollingInterests | -442.90M | 26.12M | -270.59M | -609.55M |
| NetIncomeContinuousOperations | -442.90M | 26.12M | -270.59M | -609.55M |
| TaxProvision | 5.61M | 7.30M | 3.29M | -523.00K |
| PretaxIncome | -437.30M | 33.43M | -267.30M | -610.08M |
| OtherIncomeExpense | 28.59M | 20.58M | 3.88M | 5.30M |
| SpecialIncomeCharges | 0.00 | 0.00 | -20.18M | |
| OtherSpecialCharges | 20.18M | |||
| NetNonOperatingInterestIncomeExpense | -17.60M | -23.73M | -24.60M | -22.62M |
| InterestExpenseNonOperating | 17.60M | 23.73M | 24.60M | 22.62M |
| OtherOperatingExpenses | 23.34M | 105.00K | 7.08M | -2.42M |
| DepreciationAndAmortizationInIncomeStatement | 28.89M | 32.15M | 30.69M | 15.28M |
| SellingGeneralAndAdministration | 2.05B | 1.76B | 1.42B | 1.42B |
| GeneralAndAdministrativeExpense | 2.05B | 1.76B | 1.42B | 1.42B |
| OtherGandA | 2.05B | 1.76B | 1.42B | 1.42B |
| TotalRevenue | 11.70B | 9.18B | 5.86B | 4.13B |
| OperatingRevenue | 11.70B | 9.18B | 5.86B | 4.13B |
| LossAdjustmentExpense | 10.02B | 7.33B | 4.64B | 3.28B |
| NetPolicyholderBenefitsAndClaims | 10.02B | 7.33B | 4.64B | 3.28B |
| PolicyholderBenefitsGross | 10.16B | 7.49B | 4.69B | 4.57B |
| PolicyholderBenefitsCeded | 144.15M | 159.13M | 44.74M | 1.29B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 315.00K | 315.00K | 314.60K | 314.60K |
| OrdinarySharesNumber | 297.69M | 250.49M | 229.39M | 216.29M |
| ShareIssued | 298.00M | 250.80M | 229.70M | 216.61M |
| TotalDebt | 430.10M | 299.56M | 298.78M | 298.00M |
| TangibleBookValue | 977.65M | 1.01B | 803.97M | 890.38M |
| InvestedCapital | 1.41B | 1.31B | 1.10B | 1.19B |
| NetTangibleAssets | 977.65M | 1.01B | 803.97M | 890.38M |
| CommonStockEquity | 977.65M | 1.01B | 803.97M | 890.38M |
| TotalCapitalization | 1.41B | 1.31B | 1.10B | 1.19B |
| TotalEquityGrossMinorityInterest | 980.74M | 1.02B | 806.12M | 892.40M |
| MinorityInterest | 3.09M | 2.84M | 2.15M | 2.02M |
| StockholdersEquity | 977.65M | 1.01B | 803.97M | 890.38M |
| GainsLossesNotAffectingRetainedEarnings | 18.03M | -1.83M | 1.31M | -9.71M |
| OtherEquityAdjustments | 18.03M | -1.83M | 1.31M | -9.71M |
| TreasuryStock | 2.92M | 2.92M | 2.92M | 2.92M |
| RetainedEarnings | -3.29B | -2.85B | -2.88B | -2.61B |
| AdditionalPaidInCapital | 4.26B | 3.87B | 3.68B | 3.51B |
| CapitalStock | 3.00K | 2.00K | 2.00K | 2.00K |
| CommonStock | 3.00K | 2.00K | 2.00K | 2.00K |
| PreferredStock | 0.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 5.34B | 3.82B | 2.80B | 3.63B |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| DerivativeProductLiabilities | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 430.10M | 299.56M | 298.78M | 298.00M |
| LongTermDebt | 430.10M | 299.56M | 298.78M | 298.00M |
| PayablesAndAccruedExpenses | 4.05B | 2.96B | 2.08B | 2.88B |
| Payables | 4.05B | 2.96B | 2.08B | 2.88B |
| OtherPayable | 2.59B | 1.56B | 1.06B | 1.52B |
| AccountsPayable | 1.46B | 1.40B | 1.03B | 1.37B |
| TotalAssets | 6.33B | 4.84B | 3.60B | 4.53B |
| InvestmentsAndAdvances | 1.22B | 624.46M | 689.83M | 1.40B |
| NetPPE | 88.35M | 66.79M | 61.93M | 59.89M |
| Receivables | 598.46M | 672.21M | 494.39M | 1.16B |
| OtherReceivables | 56.07M | 64.78M | 51.92M | 49.86M |
| AccountsReceivable | 542.39M | 607.43M | 442.46M | 1.11B |
| CashCashEquivalentsAndShortTermInvestments | 3.99B | 2.15B | 2.56B | 2.96B |
| OtherShortTermInvestments | 1.22B | 624.46M | 689.83M | 1.40B |
| CashAndCashEquivalents | 2.77B | 1.53B | 1.87B | 1.56B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 1.06B | 950.30M | -297.74M | 351.34M |
| RepurchaseOfCapitalStock | 0.00 | |||
| RepaymentOfDebt | 0.00 | 0.00 | -153.17M | |
| IssuanceOfDebt | 410.00M | 0.00 | 0.00 | 305.00M |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 1.35B | |
| CapitalExpenditure | -36.37M | -27.90M | -25.58M | -29.01M |
| InterestPaidSupplementalData | 12.78M | 33.69M | 23.16M | 10.08M |
| IncomeTaxPaidSupplementalData | 17.52M | 674.00K | 2.41M | 1.89M |
| EndCashPosition | 2.80B | 1.55B | 1.89B | 1.58B |
| BeginningCashPosition | 1.55B | 1.89B | 1.58B | 1.13B |
| ChangesInCash | 1.25B | -340.85M | 311.47M | 454.94M |
| FinancingCashFlow | 399.21M | 68.39M | 6.45M | 301.11M |
| CashFlowFromContinuingFinancingActivities | 399.21M | 68.39M | 6.45M | 301.11M |
| NetOtherFinancingCharges | -65.82M | 2.49M | -5.19M | -15.21M |
| ProceedsFromStockOptionExercised | 55.03M | 68.39M | 3.96M | 1.30M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 0.00 | 0.00 | 1.35B | |
| CommonStockPayments | 0.00 | |||
| CommonStockIssuance | 0.00 | 0.00 | 1.35B | |
| NetIssuancePaymentsOfDebt | 410.00M | 0.00 | 0.00 | 305.00M |
| NetLongTermDebtIssuance | 410.00M | 305.00M | -153.17M | |
| LongTermDebtPayments | 0.00 | 0.00 | -153.17M | |
| LongTermDebtIssuance | 410.00M | 0.00 | 0.00 | 305.00M |
| InvestingCashFlow | -241.06M | -1.39B | 577.19M | -226.52M |
| CashFlowFromContinuingInvestingActivities | -241.06M | -1.39B | 577.19M | -226.52M |
| NetOtherInvestingChanges | 4.28M | 3.93M | -2.28M | 1.12M |
| NetInvestmentPurchaseAndSale | -208.96M | -1.36B | 605.04M | -198.62M |
| SaleOfInvestment | 804.96M | 770.04M | 1.44B | 994.08M |
| PurchaseOfInvestment | -1.01B | -2.13B | -836.98M | -1.19B |
| NetPPEPurchaseAndSale | -36.37M | -27.90M | -25.58M | -29.01M |
| PurchaseOfPPE | -36.37M | -27.90M | -25.58M | -29.01M |
| OperatingCashFlow | 1.09B | 978.19M | -272.16M | 380.35M |
| CashFlowFromContinuingOperatingActivities | 1.09B | 978.19M | -272.16M | 380.35M |
| ChangeInWorkingCapital | 1.46B | 838.86M | -192.09M | 855.00M |
| ChangeInOtherCurrentAssets | -27.12M | -11.55M | 11.31M | -243.00K |
| ChangeInPayablesAndAccruedExpense | 1.20B | 634.49M | -856.36M | 1.00B |
| ChangeInPayable | 1.20B | 634.49M | -856.36M | 1.00B |
| ChangeInAccountPayable | 167.72M | 133.09M | -395.81M | 280.23M |
| ChangeInReceivables | 98.57M | -177.52M | 636.23M | -551.15M |
| ChangesInAccountReceivables | 89.86M | -164.67M | 638.29M | -541.95M |
| OtherNonCashItems | -10.74M | -300.00K | 28.61M | 2.99M |
| StockBasedCompensation | 87.65M | 109.82M | 159.68M | 112.33M |
| AmortizationOfSecurities | -29.79M | -26.88M | -29.37M | 2.48M |
| DeferredTax | 2.45M | -2.34M | 58.00K | -165.00K |
| DeferredIncomeTax | 2.45M | -2.34M | 58.00K | -165.00K |
| DepreciationAndAmortization | 28.89M | 32.15M | 30.69M | 15.28M |
| OperatingGainsLosses | -1.34M | -23.00K | 70.00K | 1.27M |
| GainLossOnInvestmentSecurities | -1.34M | -23.00K | 70.00K | 1.27M |
| NetIncomeFromContinuingOperations | -442.90M | 26.12M | -270.59M | -609.55M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for OSCR
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|